ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 260 filers reported holding ICU MED INC in Q3 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $263,000 | -31.3% | 1,648 | +8.4% | 0.01% | -33.3% |
| Q2 2019 | $383,000 | -4.7% | 1,520 | -9.5% | 0.01% | -7.7% |
| Q1 2019 | $402,000 | -59.2% | 1,680 | -60.8% | 0.01% | -64.9% |
| Q4 2018 | $985,000 | -10.8% | 4,288 | +9.8% | 0.04% | +8.8% |
| Q3 2018 | $1,104,000 | +240.7% | 3,904 | +253.6% | 0.03% | +240.0% |
| Q2 2018 | $324,000 | -0.9% | 1,104 | -14.8% | 0.01% | -9.1% |
| Q1 2018 | $327,000 | -19.1% | 1,296 | -30.8% | 0.01% | -21.4% |
| Q4 2017 | $404,000 | -4.3% | 1,872 | -17.6% | 0.01% | -6.7% |
| Q3 2017 | $422,000 | +12.5% | 2,272 | +4.4% | 0.02% | +7.1% |
| Q2 2017 | $375,000 | +7.4% | 2,176 | -4.9% | 0.01% | +7.7% |
| Q1 2017 | $349,000 | +5.1% | 2,288 | +1.4% | 0.01% | -13.3% |
| Q4 2016 | $332,000 | – | 2,256 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |